Page last updated: 2024-09-03

umifenovir and Hepatocellular Carcinoma

umifenovir has been researched along with Hepatocellular Carcinoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Haid, S; Pécheur, EI; Pietschmann, T1
Boriskin, YS; Pécheur, EI; Polyak, SJ1

Other Studies

2 other study(ies) available for umifenovir and Hepatocellular Carcinoma

ArticleYear
Low pH-dependent hepatitis C virus membrane fusion depends on E2 integrity, target lipid composition, and density of virus particles.
    The Journal of biological chemistry, 2009, Jun-26, Volume: 284, Issue:26

    Topics: Carcinoma, Hepatocellular; Cholesterol; Electroporation; Hepacivirus; Hepatitis C; Hepatitis C Antibodies; Humans; Hydrogen-Ion Concentration; Immunoenzyme Techniques; Immunoprecipitation; Indoles; Liposomes; Liver Neoplasms; Luciferases; RNA, Viral; Sphingomyelins; Transcription, Genetic; Tumor Cells, Cultured; Viral Envelope Proteins; Virion; Virus Internalization

2009
Arbidol: a broad-spectrum antiviral that inhibits acute and chronic HCV infection.
    Virology journal, 2006, Jul-19, Volume: 3

    Topics: Acute Disease; Antiviral Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Indoles; Interferon-beta; Membrane Fusion; Microbial Viability; Receptors, Retinoic Acid; RNA, Viral; Signal Transduction; Virus Replication

2006